A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Study sponsor: BioAge Labs, Inc. · BIOA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-11Estimated
Enrollment · participants180Estimated
Source updated2026-10-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.